The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- New: ART Drug-Drug Interactions Resource (4/25/19)
- Topics, Trends, and Updates (4/12/19)
- Frequently Asked Questions about HIV Testing (3/19/19)
- Updated Treatment of Chronic HCV with Direct-Acting Antivirals Guideline (2/21/19)
- Updated Pocket Guide to Selecting an Initial ART Regimen (2/5/19)
- Updated Selecting an Initial ART Regimen Guideline (1/28/19)
- New: When to Initiate ART Pocket Guide (12/21/18)
- Medscape Commentary: Preventing HPV in Patients With HIV: New Guidelines (10/26/18)
- AETC NCRC Updates (4/25/19)
- HHS Pediatric Antiretroviral Treatment Guidelines Updated (4/16/19)
- NYC Health Information: Buprenorphine—An Office-Based Treatment for Opioid Use Disorder (4/11/19)
- FDA Approves First Two-Drug Complete Regimen for HIV-Infected Patients Who Have Never Received Antiretroviral Treatment (4/8/19)
- AIDSinfo: Updates to the Pneumocystis Pneumonia Section of the Adult and Adolescent Opportunistic Infections Guidelines (3/28/19)
Relative Contributions of Traditional Modifiable Risk Factors to Morbidity Among People with HIV: Compared with people who do not have HIV, people with HIV, even those with well-controlled disease, have an elevated risk of MI, ESLD, ESRD, and NADCs . . . Read more
Performance of the ACC/AHA CVD Risk Calculator Among People With HIV: In December 2018, researchers reported their evaluation of the utility of 2 guidelines for statin use in predicting subsequent cardiovascular disease... Read more
- 4/26/19: KY AETC: 10th Annual KY AETC HIV/HCV Intensive Conference (Lexington, KY)
- 4/29/19: Johns Hopkins Medicine: 29th Annual Clinical Care of the Patient with HIV & Care of Patients with Viral Hepatitis (Baltimore, MD)
- 5/01/19: Midwest AETC: HIV/HCV Mini-Residency Program (Chicago, IL)
- 5/03/19: CEI/Mount Sinai: NYS 2019 Clinical Conference on HIV & HCV (Fairport, NY)
- 5/03/19: NECA AETC: Pain Contracting and Drug Testing in the Outpatient Setting (Stratford, NJ)
- 4/30/19: IAS-USA: Engaging Patients in HIV Care: Understanding Intimate Partner Violence (IPV) and Its Implications for Treatment
- 5/01/19: CEI HIV ECHO: Opioid/Naloxone
- 5/01/19: MidAtlantic AETC: HIV & Women: PrEP
- 5/01/19: CEI HIV ECHO: Best Practices for Implementing Buprenorphine
- 5/03/19: NECA AETC: Pain Contracting and Drug Testing in the Outpatient Setting